Published in Lasers Med Sci on March 24, 2007
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Photodynamic therapy for cancer. Nat Rev Cancer (2003) 8.00
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res (1976) 4.60
Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol (1987) 2.50
Open "back door" in a molecular dynamics simulation of acetylcholinesterase. Science (1994) 2.37
An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. Proc Natl Acad Sci U S A (1993) 2.14
Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today (1999) 2.05
Definition of type I and type II photosensitized oxidation. Photochem Photobiol (1991) 1.75
Acetylcholinesterase: electrostatic steering increases the rate of ligand binding. Biochemistry (1993) 1.69
Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res (2003) 1.48
Photomodification of biological membranes with emphasis on singlet oxygen mechanisms. Photochem Photobiol (1987) 1.29
Role of activated oxygen species in photodynamic therapy. Methods Enzymol (2000) 1.08
PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging (2006) 0.94
A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors. J Biomed Sci (2003) 0.92
The role of molecular oxygen in the photodynamic effect of phthalocyanines. Radiat Res (1986) 0.92
Oxygen dependency of photocytotoxicity with haematoporphyrin derivative. Photochem Photobiol (1984) 0.92
Catalase inactivation following photosensitization with tetrasulfonated metallophthalocyanines. Photochem Photobiol (1995) 0.83
Laser intensity and wavelength dependence of Rose-Bengal-photosensitized inhibition of red blood cell acetylcholinesterase. Biochim Biophys Acta (1989) 0.83
Two-step photoactivation of hematoporphyrin by excimer-pumped dye-laser pulses. J Photochem Photobiol B (1987) 0.82
Intensity-dependent enzyme photosensitization using 532 nm nanosecond laser pulses. Photochem Photobiol (1996) 0.81
Photodynamic activity of substituted zinc trisulfophthalocyanines: role of plasma membrane damage. Photochem Photobiol (2007) 0.79
Molecular mechanisms of photosensitization. Biochimie (1986) 0.79
Activation and inactivation of acetylcholinesterase by metal ions. Can J Biochem (1981) 0.78
Two-photon absorption of copper tetrasulfophthalocyanine induces phototoxicity towards Jurkat cells in vitro. Photochem Photobiol Sci (2006) 0.78
An efficient oxygen independent two-photon photosensitization mechanism. Photochem Photobiol (1994) 0.78
Ultrafast studies of the excited-state dynamics of copper and nickel phthalocyanine tetrasulfonates: potential sensitizers for the two-photon photodynamic therapy of tumors. Photochem Photobiol Sci (2004) 0.77
Proposal of modified mechanisms for photodynamic therapy. J Photochem Photobiol B (1992) 0.77
Activation of acetylcholine esterase (ACHE) as a sign for erythrocyte membrane alteration. Exp Pathol (1984) 0.77
Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer. J Nucl Med (2006) 1.59
Cyclotron production of 99mTc: an approach to the medical isotope crisis. J Nucl Med (2010) 1.55
Targeted photodynamic therapy via receptor mediated delivery systems. Adv Drug Deliv Rev (2004) 1.37
A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer. Mol Imaging Biol (2007) 1.11
The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats. Mol Imaging Biol (2006) 0.96
PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging (2006) 0.94
Synthesis and photodynamic activity of novel asymmetrically substituted fluorinated phthalocyanines. Bioconjug Chem (2005) 0.94
Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Bioorg Med Chem Lett (2007) 0.87
Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol (2004) 0.86
Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT. J Nucl Med (2008) 0.85
Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action. Immunology (2010) 0.84
Positron emission tomography imaging of tumor response after photodynamic therapy. J Environ Pathol Toxicol Oncol (2006) 0.83
Cancer radiotherapy based on femtosecond IR laser-beam filamentation yielding ultra-high dose rates and zero entrance dose. Proc Natl Acad Sci U S A (2012) 0.81
(68)Ga/DOTA- and (64)Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes. Bioconjug Chem (2013) 0.80
18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals. Steroids (2002) 0.80
Photodynamic activity of substituted zinc trisulfophthalocyanines: role of plasma membrane damage. Photochem Photobiol (2007) 0.79
Synthesis and biological activities of nucleoside-estradiol conjugates. Bioorg Med Chem Lett (2005) 0.79
Synthesis and biological activities of phthalocyanine-estradiol conjugates. Bioorg Med Chem Lett (2003) 0.79
Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate. Bioorg Med Chem Lett (2008) 0.79
Structure-photodynamic activity relationships of substituted zinc trisulfophthalocyanines. Bioconjug Chem (2005) 0.78
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice. Eur J Nucl Med Mol Imaging (2008) 0.78
Attenuation of photodynamically induced apoptosis by an RGD containing peptide. Photochem Photobiol Sci (2002) 0.78
Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FES. Nucl Med Biol (2007) 0.78
Two-photon absorption of copper tetrasulfophthalocyanine induces phototoxicity towards Jurkat cells in vitro. Photochem Photobiol Sci (2006) 0.78
Introduction of bulky perfluoroalkyl groups at the periphery of zinc perfluorophthalocyanine: chemical, structural, electronic, and preliminary photophysical and biological effects. Angew Chem Int Ed Engl (2002) 0.78
Ultrafast studies of the excited-state dynamics of copper and nickel phthalocyanine tetrasulfonates: potential sensitizers for the two-photon photodynamic therapy of tumors. Photochem Photobiol Sci (2004) 0.77
Electron transfer in DNA duplexes containing 2-methyl-1,4-naphthoquinone. Nucleic Acids Res (2004) 0.77
Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells. Photochem Photobiol (2008) 0.77
(18)F-labelling of A-ring substituted 16alpha-fluoro-estradiols as potential radiopharmaceuticals for PET imaging. Steroids (2008) 0.76
Synthesis of the 7alpha-cyano-(17alpha,20E/Z)-[125I]iodovinyl-19-nortestosterones: potential radioligands for androgen and progesterone receptors. Steroids (2003) 0.76
PET imaging using 64Cu-labeled sulfophthalocyanines: synthesis and biodistribution. Bioorg Med Chem Lett (2011) 0.76
Phthalocyanine-peptide conjugates: receptor-targeting bifunctional agents for imaging and photodynamic therapy. J Med Chem (2013) 0.76
Two-photon absorption cross section of excited phthalocyanines by a femtosecond Ti-sapphire laser. Photochem Photobiol Sci (2009) 0.76
Pd-catalyzed Heck reaction for the synthesis of isomeric metallo tetravinylsulfo phthalocyanines and their photosensitizing properties. Photochem Photobiol Sci (2009) 0.76
Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780). Nucl Med Biol (2004) 0.76
Metallophthalocyanines photosensitize the breakdown of (hydro)peroxides in solution to yield hydroxyl or alkoxyl and peroxyl free radicals via different interaction pathways. Photochem Photobiol (2003) 0.76
Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography. Nucl Med Biol (2007) 0.75
Bromines on N-allyl position of cationic porphyrins affect both radio- and photosensitizing properties. Photochem Photobiol Sci (2008) 0.75
Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model. Photochem Photobiol Sci (2014) 0.75
Synthesis and biological properties of 7alpha-cyano derivatives of the (17alpha,20E/Z)-[125I]iodovinyl- and 16alpha-[125I]iodo-estradiols. Steroids (2003) 0.75
Synthesis of nitrile derivatives of estrogens. Bioorg Med Chem Lett (2002) 0.75
Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer. Photochem Photobiol Sci (2010) 0.75
Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model. Mol Imaging Biol (2013) 0.75
Phthalocyanine-peptide conjugates via palladium-catalyzed cross-coupling reactions. J Org Chem (2011) 0.75
Improved detection sensitivity of D-mannitol crystalline phase content using differential spectral phase shift terahertz spectroscopy measurements. Opt Express (2011) 0.75